Pearl River Capital, LLC Ionis Pharmaceuticals Inc Transaction History

Pearl River Capital, LLC

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 13, 2024	SELL	$36.45 - $47.7 $720,689 - $943,124	-19,772 Reduced 76.17%	6,187 $294,000
Q1 2024 May 14, 2024	BUY	$42.03 - $53.55 $1.09 Million - $1.39 Million	25,959 New	25,959 $1.13 Million
Q2 2022 Aug 12, 2022	SELL	$31.71 - $43.0 $321,951 - $436,579	-10,153 Closed	0 $0
Q1 2022 May 13, 2022	BUY	$29.88 - $37.04 $303,371 - $376,067	10,153 New	10,153 $376,000
Q2 2020 Aug 10, 2020	SELL	$46.85 - $61.05 $16,069 - $20,940	-343 Closed	0 $0
Q1 2020 May 06, 2020	BUY	$41.6 - $63.4 $14,268 - $21,746	343 New	343 $16,000

403

136M

862K

582K

Ticker IONS
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 141,940,992
Market Cap $5.35B
Description
Ionis Pharmaceuticals, Inc. discovers and develops RNA-targeted therapeutics in the United States. The company offers SPINRAZA for spinal muscular atrophy (SMA) in pediatric and adult patients; TEGSEDI, an injection for the treatment of polyneuropathy of hereditary transthyretin-mediated amyloidosis in adults; and WAYLIVRA, a treatment for famil...

Get notified when there are updates to the investment portfolio of Pearl River Capital, LLC, based on Form 13F filings with the SEC.

Stay updated on Pearl River Capital, LLC with notifications on news.